MOA: competitive nonselective phosphodiesterase inhibitor, which raises intracelluar cAMP, activates PKA, inhibits TNF-alpha and inhibits leukotriene synthesis and reduces inflammation and innate immunity Additive maintenece therapy for poorly conrolled asthma using inhaled glucocorticoids primary maintenance for those using PO meds primary maintenance for those having difficulty with inhalors additive for those in ICU no responding to beta-2 agonist

Theophylline and Flex Review information Flashcards by Addie Agboola

MOA: competitive nonselective phosphodiesterase inhibitor, which raises intracelluar cAMP, activates PKA, inhibits TNF-alpha and inhibits leukotriene synthesis and reduces inflammation and innate immunity
Additive maintenece therapy for poorly conrolled asthma using inhaled glucocorticoids
primary maintenance for those using PO meds
primary maintenance for those having difficulty with inhalors
additive for those in ICU no responding to beta-2 agonist

Theophylline

How well did you know this?

Not at all

Perfectly